Bioadaptives (BDPT) Cash from Operations (2019 - 2025)
Bioadaptives' Cash from Operations history spans 7 years, with the latest figure at 155828.0 for Q4 2025.
- Quarterly results put Cash from Operations at 155828.0 for Q4 2025, down 54.99% from a year ago — trailing twelve months through Dec 2025 was 516025.0 (down 106.81% YoY), and the annual figure for FY2025 was 516025.0, down 106.81%.
- Cash from Operations for Q4 2025 was 155828.0 at Bioadaptives, down from 151309.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 19461.0 in Q1 2023 to a low of 155828.0 in Q4 2025.
- The 5-year median for Cash from Operations is 58614.0 (2021), against an average of 68761.25.
- The sharpest move saw Cash from Operations plummeted 258.98% in 2021, then soared 68.18% in 2023.
- Year by year, Cash from Operations stood at 35403.0 in 2021, then grew by 22.31% to 27504.0 in 2022, then tumbled by 231.94% to 91296.0 in 2023, then decreased by 10.12% to 100538.0 in 2024, then plummeted by 54.99% to 155828.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods came in at 155828.0, 151309.0, and 110982.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.